What do mosaic RASopathies tell us about carcinogenesis?

Siegel, D H; Tower, R; Drolet, B A

Siegel, D H; Tower, R; Drolet, B A.

Afiliação

Siegel DH; Department of Dermatology, Division of Hematology, Oncology and Bone Marrow Transplant, Medical College of Wisconsin, Milwaukee, WI, U.S.A.
Tower R; Department of Pediatrics, Division of Hematology, Oncology and Bone Marrow Transplant, Medical College of Wisconsin, Milwaukee, WI, U.S.A.
Drolet BA; Department of Dermatology, Division of Hematology, Oncology and Bone Marrow Transplant, Medical College of Wisconsin, Milwaukee, WI, U.S.A.

Br J Dermatol ; 179(5): 1031-1032, 2018 11.

Article em En | MEDLINE | ID: mdl-30387507

Assuntos

Nevo Pigmentado; Rabdomiossarcoma; Adulto; Carcinogênese; Criança; Humanos; Mosaicismo; Proteínas Proto-Oncogênicas p21(ras)/genética; Neoplasias Cutâneas

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rabdomiossarcoma / Nevo Pigmentado Limite: Adult / Child / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google